Advances in identification techniques for nontuberculous mycobacteria strains

doi:10.3969/j.issn.2095-3755.2019.02.015

Abstract

Abstract:

Nontuberculous mycobacteria (NTM) widely exist in nature and can cause disease in humans, and the incidence is increasing year by years. Accurate identification of bacterial species is the prerequisite for precision medicine. In this paper, the experimental principles, advantages, disadvantages and accuracy of the traditional identification methods, bacterial components and molecular biological identification methods were reviewed, in order to provide reference for medical workers.

Key words: Mycobacteria, atypical, Diagnosis, differential, Diagnostic techniques and procedures, Review

Xuan ZENG,Jian LU,Yu-xiang XU,Tao-sheng YE. Advances in identification techniques for nontuberculous mycobacteria strains[J]. Journal of Tuberculosis and Lung Health , 2019, 8(2): 146-148. doi: 10.3969/j.issn.2095-3755.2019.02.015

References 27

[1]	王卫萍, 邵海枫. 非结核分枝杆菌及实验室诊断研究进展. 临床检验杂志, 2015, 33(10): 737-739.
[2]	Henkle E, Hedberg K, Schafer SD, et al.Surveillance of extrapulmonary nontuberculous mycobacteria infections, Oregon, USA, 2007—2012. Emerg Infect Dis, 2017, 23(10): 1627-1630.
[3]	Svensson E, Jensen ET, Rasmussen EM, et al.Mycobacterium chimaera in heater-cooler units in Denmark related to isolates from the United States and United Kingdom. Emerg Infect Dis, 2017, 23(3): 507-509.
[4]	Chanda-Kapata P, Kapata N, Klinkenberg E, et al.Non-tuberculous mycobacteria (NTM) in Zambia: prevalence, clinical, radiological and microbiological characteristics. BMC Infect Dis, 2015, 15: 500.
[5]	Yu X, Liu P, Liu G, et al.The prevalence of non-tuberculous mycobacterial infections in mainland china: systematic review and meta-analysis. J Infect, 2016, 73(6): 558-567.
[6]	Morimoto K, Hasegawa N, Izumi K, et al.A laboratory-based analysis of nontuberculous mycobacterial lung disease in Japan from 2012 to 2013. Ann Am Thorac Soc, 2016, 14(1): 49-56.
[7]	谢爱蓉, 赵晓春. 结核分枝杆菌快速培养法的进展. 检验医学, 2010, 25(4): 327-329.
[8]	Azadi D, Motallebirad T, Ghaffari K, et al.Mycobacteriosis and tuberculosis: laboratory diagnosis. Open Microbiol J, 2018, 12: 41-58.
[9]	Alcaide F, Amlerová J, Bou G, et al.How to: identify non-tuberculous mycobacterium species by using MALDI-TOF mass spectrometry. Clin Microbiol Infect, 2018, 24(6): 599-603.
[10]	Rodriguez-Temporal D, Perez-Risco D, Struzka EA, et al.Impact of updating the MALDI-TOF MS database on the identification of nontuberculous mycobacteria. J Mass Spectrom, 2017, 52(9): 597-602.
[11]	Kodana M, Tarumoto N, Kawamura T, et al.Utility of the MALDI-TOF MS method to identify nontuberculous mycobacteria. J Infect Chemother, 2016, 22(1): 32-35.
[12]	Jagielski T, Minias A, van Ingen J,, et al Methodological and clinical aspects of the molecular epidemiology of Mycobacterium tuberculosis and other mycobacteria. Clin Microbiol Rev, 2016, 29(2): 239-290.
[13]	Kim SH, Shin JH.Identification of nontuberculous mycobacteria using multilocous sequence analysis of 16S rRNA, hsp65, and rpoB. J Clin Lab Anal, 2018, 32(1).
[14]	Nour-Neamatollahie A, Ebrahimzadeh N, Siadat SD, et al.Distribution of non-tuberculosis mycobacteria strains from suspected tuberculosis patients by heat shock protein 65 PCR-RFLP. Saudi J Biol Sci, 2017, 24(6): 1380-1386.
[15]	Saifi M, Jabbarzadeh E, Bahrmand AR, et al.HSP65-PRA identification of non-tuberculosis mycobacteria from 4892 samples suspicious for mycobacterial infections. Clin Microbiol Infect, 2013, 19(8): 723-728.
[16]	黄明翔, 万康林, 陈力舟, 等. 福建省临床分离非结核分枝杆菌菌种分布研究. 中国人兽共患病学报, 2014, 30(12): 1227-1230. doi: 10.3969/cjz.j.issn.1002-2694.2014.12.012
[17]	Jung YJ, Kim JY, Song DJ, et al.Evaluation of three real-time PCR assays for differential identification of Mycobacterium tuberculosis complex and nontuberculous mycobacteria species in liquid culture media. Diagn Microbiol Infect Dis, 2016, 85(2): 186-191.
[18]	Choi YJ, Kim HJ, Shin HB, et al.Evaluation of peptide nucleic acid probe-based real-time PCR for detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in respiratory specimens. Ann Lab Med,2012,32(4): 257-263. doi: 10.3343/alm.2012.32.4.257
[19]	Ali RM, Alsudani AA. Discordance between GeneXpert assay and conventional drug-susceptibility testing in detecting rifampicin-resistant tuberculosis: A perspective of the line probe assay. Int J Mycobacteriol, 2016, 5 Suppl 1: S193-S194.
[20]	陈琛, 马远征. 分子线性探针测定法在结核病诊断中的研究进展. 中国防痨杂志, 2016, 38(3): 218-221. doi: 10.3969/j.issn.1000-6621.2016.03.013
[21]	Singh AK, Maurya AK, Umrao J, et al.Role of GenoType^® Mycobacterium common Mycobacteria/additional species assay for rapid differentiation between Mycobacterium tuberculosis complex and different species of non-tuberculous mycobacteria. J Lab Physicians, 2013, 5(2): 83-89.
[22]	Wu X, Zhang J, Liang J, et al.Comparison of three methods for rapid identification of mycobacterial clinical isolates to the species level. J Clin Microbiol, 2007, 45(6): 1898-1903.
[23]	唐曙明, 李爱敏, 陈海霞, 等. 基因芯片快速鉴定分枝杆菌菌种方法的建立. 重庆医学, 2015, 44(11):1516-1518.
[24]	Srilohasin P, Chaiprasert A, Tokunaga K, et al.Novel DNA chip based on a modified DigiTag2 assay for high-throughput species identification and genotyping of Mycobacterium tuberculosis complex isolates. J Clin Microbiol, 2014, 52(6): 1962-1968. doi: 10.1128/JCM.00153-14
[25]	Zimenkov DV, Kulagina EV, Antonova OV, et al.Evaluation of a low-density hydrogel microarray technique for mycobacterial species identification. J Clin Microbiol, 2015, 53(4): 1103-1114.
[26]	Ke R, Mignardi M, Hauling T, et al.Fourth generation of next-generation sequencing technologies: promise and consequences. Hum Mutat, 2016, 37(12): 1363-1367.
[27]	Olaru ID, Patel H, Kranzer K, et al. Turnaround time of whole genome sequencing for mycobacterial identification and drug susceptibility testing in routine practice. Clin Microbiol Infect, 2018, 24(6): 659.e5-659.e7.